Are anti-diabetic drugs the silver bullet for the obesity epidemic? - Hospital Healthcare Europe

Beneficial weight loss induced by anti-diabetic medicines provides a much needed impetus in the fight against the global obesity epidemic.

ars.els-cdn.com/content/image/1-s2.0-S019697811730

PDF) Incorporation of public hospitals: A Silver Bullet against overcapacity, managerial bottlenecks and resource constraints?: Case studies from Austria and Estonia

Science' names anti-obesity drugs the scientific breakthrough of the year, Science

New Diabetes Drugs Like Ozempic Are Changing How Patients Are Treated - WSJ

New pandemic wave strikes hardest at people with pre-existing conditions – POLITICO

Effective coverage of medical treatment for hypertension, diabetes and dyslipidaemia in Japan: An analysis of National Health and Nutrition Surveys 2003–2017 - Nayu Ikeda, Nobuo Nishi, Takehiro Sugiyama, Hiroyuki Noda, Mitsuhiko Noda, 2021

MUSC Catalyst News, MUSC

Exclusive: Wegovy, other weight loss drugs 'no silver bullet', says WHO amid obesity review

Will a UK Government pilot scheme expanding access to an anti-diabetic drug reduce obesity-related complications? - Hospital Healthcare Europe

Impact of Liver Functions by Repurposed Drugs for COVID-19 Treatment

Diseases, Free Full-Text

Frontiers Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease

A new class of drugs for weight loss could end obesity

Mission, Vision